NCT05488145 2026-04-17A Feasibility Trial of a Web Based App Intervention in Hormone Positive Breast Cancer Patients to Improve Adherence to Endocrine TherapyEmory UniversityPhase NA Terminated21 enrolled
NCT04249622 2025-09-16Rifaximin for the Treatment of Gastrointestinal Toxicities Related to Pertuzumab-Based Therapy in Patients With Stage I-III HER2 Positive Breast CancerMayo ClinicPhase 2 Terminated20 enrolled 13 charts